This review of the the effectiveness of different mandibular advancement devices for obstructive sleep apnoea included 50 RCTS. While the findins suggest that mono-bloc MADs are more effective duo-bloc devices the quality of the available evidence is very low.
[read the full story...]
21 studies mainly retrospective studies were included in this review of the dental and skeletal effects of mandibular advancement devices in treatment of obstructive sleep apnoea. while the findings suggest a number of potential side effects the quality of the available evidence in low.
[read the full story...]
Obstructive sleep apnoea-hypopnoea (OSAH) affects 2-7% of adults. This trial compared 3 mandibular advancement devices with no treatment for mild disease and found benefits over the short term for a range of outcomes including Apnoea-Hypopnoea Index, the Epworth Sleepiness Scale and cost-effectiveness.
[read the full story...]
Obstructive sleep apnoea (OSA) can result in day-time sleepiness, neurocognitive decline and, in the long terms cardiovascular problems. While nasal continuous positive airway pressure (CPAP) is the standard treatment for OSA oral appliances (OAs) have been used as an alternative approach. The aim of this review was to assess the effectiveness of OAs that advanced [read the full story…]
Another new critical summary form the ADA-EBD Center looks at a 2011 systematic review by Ahrens et al. The aim of the original review was to compare the effectiveness of different design features of mandibular advancement devices (MADs) in reducing the severity of obstructive sleep apnea (OSA). The appraiser notes that some relevant studies may [read the full story…]
Obstructive sleep apnoea/hypopnoea syndrome (OSAHS) is though to affect around 4% of the male and 2% of the female population of North America. Continuous positive airway pressure (CPAP) particularly for moderate to severe cases. The aim of this cross-over trial was to compare the two types of mandibular advancement appliances (MAAs) with different structures, retention [read the full story…]
Randomized controlled trials have previously addressed the efficacy of mandibular advancement devices (MADs) in the treatment of obstructive sleep apnoea (OSA). The control used in these studies is usually nasal continuous positive airway pressure (nCPAP). It is frequently found to be superior to MAD therapy. In most of these studies nCPAP was titrated objectively but [read the full story…]
